Abstract:In the present work, amino acid modified cephalotaxine derivatives were designed and synthesized based on the active Harringtonine. Some of them showed more efficient anti‐SARS‐CoV‐2 activities in inhibiting pseudovirus infection, which may attribute to binding to the key residue of ACE2 according to the molecular docking. The severe acute respiratory syndrome coronavirus (SARS‐CoV‐2) pandemic has triggered a significant impact on global public health security, it is urgent to develop effective antiviral drugs. Previous studies have found that binding to ACE2 is a key step in the invasion of SARS‐CoV‐2 into host cells, so virus invasion can be inhibited by blocking ACE2, but there are few reports on this kind of specific inhibitor. Our previous study found that Harringtonine (HT) can inhibit the entry of SARS‐CoV‐2 spike pseudovirus into ACE2h cells, but its relatively high cytotoxicity limits its further development. Amino acid modification of the active components can increase their solubility and reduce their cytotoxicity. Therefore, in this study, seven new derivatives were synthesized by amino acid modification of its core structure Cephalotaxine. The target compounds were evaluated by cell viability assay and the SARS‐CoV‐2 spike pseudovirus entry assay. Compound CET‐1 significantly inhibited the entry of pseudovirus into ACE2h cells and showed less cytotoxicity than HT. Molecular docking results showed that CET‐1 could bind TYR83, an important residue of ACE2, just like HT. In conclusion, our study provided a novel compound with more potential activity and lower toxicity than HT on inhibiting the SARS‐CoV‐2 spike pseudovirus infection, which makes it possible to be a lead compound as an antiviral drug in the future.

Synthesis of a Novel Hemicucurbituril and Its Inhibitory Activity of Cathepsin L

Cyanobacterial peptides as a prototype for the design of cathepsin D inhibitors.

Design and Synthesis of Novel Cathepsin C Inhibitors with Anti-Inflammatory Activity

Design, synthesis, and bioactivities of tasiamide B derivatives as cathepsin D inhibitors.

Cinnamaldehyde hydrazone derivatives as potential cathepsin B inhibitors: parallel in-vitro investigation in liver and cerebrospinal fluid

Substituted 4H-3,1-benzoxazine-4-one Derivatives as Inhibitors of Cathepsin G

Cathepsin-Targeting SARS-CoV-2 Inhibitors: Design, Synthesis, and Biological Activity

Interactions of a Low Molecular Weight Inhibitor from Streptomyces sp. MBR04 with Human Cathepsin D: Implications in Mechanism of Inactivation

Synthesis, Biological Evaluation, and Computational Studies of Schiff's Base Derivatives of 4‐(4‐Amino‐5‐mercapto‐4H‐1,2,4‐triazol‐3‐yl)benzenesulfonamide as Cathepsin B Inhibitors

The Synthesis, Structure and Activity Evaluation of Pyrogallol and Catechol Derivatives As Helicobacter Pylori Urease Inhibitors

Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy

Discovery, synthesis and mechanism study of 2,3,5-substituted [1,2,4]-thiadiazoles as covalent inhibitors targeting 3C-Like protease of SARS-CoV-2

Synthesis and Biological Evaluation of Novel Piperidine-3-Carboxamide Derivatives as Anti-Osteoporosis Agents Targeting Cathepsin K

New Natural Inhibitors of Human Cathepsin B

Synthesis, Biological Evaluation, and Molecular Modeling of Cinnamic Acyl Sulfonamide Derivatives As Novel Antitubulin Agents

Synthesis and Biological Evaluation of Curcumin Derivatives Modified with Α-Amino Boronic Acid As Proteasome Inhibitors.

Structural Elucidation and Antiviral Activity of Covalent Cathepsin L Inhibitors

Synthesis and anti‐SARS‐CoV‐2 activity of amino acid modified cephalotaxine derivatives

An efficient and concise synthesis of a selective small molecule non-peptide inhibitor of cathepsin L: KGP94

Highly Selective Aza-Nitrile Inhibitors for Cathepsin K, Structural Optimization and Molecular Modeling

2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of Hepatitis C Virus with a Novel Mechanism of Action